Sawbones: Patents vs. Life-Saving Drugs

Sawbones: Patents vs. Life-Saving Drugs

Up next

Sawbones: Kratom

Maybe you've heard of kratom, a substance being sold as a 'natural' energy substance. With its alarmingly growing popularity, Dr. Sydnee and Justin look into what exactly it is, what it really does, and whether you should take it. (Spoiler: you should not). Music: "Medicines" by ...  Show more

Sawbones: Hantavirus, Part 2

The recent outbreak of human-communicable Hantavirus on a cruise ship continues to change rapidly and the U.S. continues to lag behind other nations in its response. This week on Sawbones, an update on the situation and some thoughts about the future of disease management in a co ...  Show more

Recommended Episodes

Why One Drug Company Held Back a Better Drug
The Daily

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.

Rebecca Robbi ...

  Show more

Why are drug prices so high? Investigating the outdated US patent system | Priti Krishtel
TED Health

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

Long Reads: Big Pharma's Toxic Record w/ Nick Dearden
Jacobin Radio

From the HIV/AIDS crisis, to the opioid epidemic, to the COVID-19 pandemic, pharmaceutical corporations have been accused of profiteering at the expense of countless lives. Nick Dearden, director of Global Justice Now and the author of a new book called <a href="https://www.ve ...

  Show more

Why are drug prices so high? Investigating the outdated US patent system | Priti Krishtel
TED Talks Daily

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more